Sex Counseling with Groups in a General Hospital

1984 ◽  
Vol 65 (1) ◽  
pp. 19-26 ◽  
Author(s):  
Ellen Macaluso ◽  
Anne H. Berkman
Keyword(s):  
Small Group ◽  
General Hospital ◽  
Social Worker ◽  
Cost Effective ◽  
Sexual Problem ◽  
Counseling Program ◽  
Group Program ◽  
Sex Counseling ◽  
Health Related

Meeting a need not served by many hospitals, a sex counselor and a social worker developed a small group program to help patients deal with a health-related sexual problem. Its effectiveness indicates that it can serve as a model for a cost-effective, hospital-wide sex counseling program.

scholarly journals Fostering the practice of rooming-in in newborn care

2013 ◽  
Vol 3 (2) ◽  
pp. 177-178
Author(s):  
Saurabh R. Shrivastava ◽  
Prateek S. Shrivastava ◽  
Jegadeesh Ramasamy
Keyword(s):  
Institutional Delivery ◽  
Newborn Care ◽  
Cost Effective ◽  
Timely Initiation ◽  
Cost Effective Approach ◽  
Health Related ◽  
And Child Health ◽  
Timely Initiation Of Breastfeeding ◽  
Initiation Of Breastfeeding ◽  
Universal Application

Practice of rooming-in meant that baby and mother stayed together in the same room day and night in the hospital, right from the time of delivery till the time of discharge. Adoption of rooming-in offers multiple benefits to the newborn, mother, and mother-child as a unit. It is a cost-effective approach wherefewer instruments are required and spares additional manpower. Rooming-in endeavors the opportunity to contribute signifi cantly in the child’s growth, development and survival by assisting in timely initiation of breastfeeding. To ensure universal application of rooming-in in hospitals, a comprehensive and technically sound strategy should be formulated and implemented with active participation of healthcare professionals. Measures such as advocating institutional delivery through outreach awareness activities; adoption of baby-friendly hospital initiative; inculcating a sense of ownership among health professionals, can be strategically enforced for better maternal and child health related outcomes.

Smoking Cessation Therapy is a Cost-Effective Intervention to Avoid Tooth Loss in Subjects With Periodontitis – An Economic Evaluation 

2021 ◽  
Author(s):  
Maria Luisa Silveira Souto ◽  
Fernanda Campos Almeida Carrer ◽  
Mariana Minatel Braga ◽  
Cláudio Mendes Pannuti
Keyword(s):  
Smoking Cessation ◽  
Cost Effectiveness ◽  
Oral Health ◽  
Incremental Cost ◽  
Tooth Loss ◽  
Cost Effective ◽  
Cost Utility ◽  
Health Related ◽  
Per Oral ◽  
Smoking Cessation Therapy

Abstract Background: Smokers present a higher prevalence and severity of periodontitis and, consequently, higher prevalence of tooth loss. Smoking cessation improves the response to periodontal treatment and reduces tooth loss. So, the aim of this study was evaluated the efficiency in resources allocation when implementing smoking cessation therapy vs. its non-implementation in smokers with periodontitis. Methods: We adopted the Brazilian public system perspective to determine the incremental cost-effectiveness (cost per tooth loss avoided) and cost-utility (cost per oral-related quality-adjusted life-year ([QALY] gained) of implementing smoking cessation therapy. Base-case was defined as a 48 years-old male subject and horizon of 30 years. Effects and costs were combined in a decision analytic modeling framework to permit a quantitative approach aiming to estimate the value of the consequences of smoking cessation therapy adjusted for their probability of occurrence. Markov models were carried over annual cycles. Sensitivity analysis tested methodological assumptions. Results: Implementation of smoking cessation therapy had an average incremental cost of U$60.58 per tooth loss avoided and U$4.55 per oral related-QALY gained. Considering uncertainties, the therapy could be cost-effective in the most part of simulated cases, even being cheaper and more effective in 53% of cases in which the oral-health related outcome is used as effect. Considering a willingness-to-pay of US$100 per health effect, smoking cessation therapy was cost-effective, respectively, in 81% and 100% of cases in cost-utility and cost-effectiveness analyses. Conclusions: Implementation of smoking cessation therapy may be cost-effective, considering the avoidance of tooth loss and oral health-related consequences to patients.

Closing the Gap

2010 ◽  
pp. 38-59 ◽  
Author(s):  
Malina Jordanova
Keyword(s):  
Information And Communication Technologies ◽  
Health Sector ◽  
Cost Effective ◽  
Communication Technologies ◽  
Healthcare Services ◽  
World Health ◽  
World Health Assembly Resolution ◽  
Health Related ◽  
Information And Communication ◽  
The Cost

Brought to life by contemporary changes of our world, e-health offers enormous possibilities. In the World Health Organization’s World Health Assembly resolution on e-health, WHO has defined e-health as the cost-effective and secure use of information and communication technologies in support of health and health-related fields, including healthcare services, health surveillance, health literature, and health education (WHO, 2005). It is impossible to have a detailed view of its potential as e-health affects the entire health sector and is a viable tool to provide routine, as well as specialized, health services. It is able to improve both the access to, and the standard of, health care. The aim of the chapter is to focus on how e-health can help in closing one gap - optimizing patient care. The examples included and references provided are ready to be introduced in practice immediately. Special attention is dedicated to cost effectiveness of e-health applications.

Extensive reclamation technologies, assets for the development of water reuse in the Mediterranean

2003 ◽  
Vol 3 (4) ◽  
pp. 209-216 ◽  
Author(s):  
F. Brissaud ◽  
P. Xu ◽  
M. Auset
Keyword(s):  
Water Reuse ◽  
Cost Effective ◽  
Golf Courses ◽  
Public Parks ◽  
Reclaimed Wastewater ◽  
Treatment Techniques ◽  
Health Related ◽  
Market Gardening ◽  
The Mediterranean ◽  
Microbial Removal

In the Mediterranean, the main water reuse application is and will long remain irrigation. Irrigation of public parks, landscape, golf courses, market gardening and orchards is expected to develop rapidly. Such uses require the microbial decontamination of reclaimed wastewater. Extensive reclamation technologies are well adapted to the Mediterranean context for their easy and cost effective O&M; however their ability to reliably meet health related standards have been questioned. The paper reviews the main factors of variations in the bacterial abatement provided by extensive treatment techniques - stabilisation reservoirs, ponds and infiltration percolation. Thanks to advances in the knowledge and modelling of disinfection mechanisms, the predictability of microbial decontamination by extensive technologies is being significantly improved; the development of better design tools leading to reliable treatments is foreseen. However, due to limitations in the microbial removal, extensive techniques cannot meet highly conservative requirements. Extensive techniques will play an important part in the development of water reuse and fresh water savings in the Mediterranean as far as water quality standards only aim at limiting health risks to an acceptable level.

Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases from renal cell carcinoma: Comparison between France, Germany, and the United Kingdom

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 5106-5106
Author(s):  
M. F. Botteman ◽  
S. Kaura
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Cost Effective ◽  
Sensitivity Analyses ◽  
Life Years ◽  
Health Related ◽  
Skeletal Related Events ◽  
The Uk

5106 Background: Zoledronic acid (ZOL) significantly reduces the risk of new skeletal-related events (SREs) in patients (pts) with bone metastases from RCC. This study assessed and compared the cost-effectiveness of ZOL in pts with RCC from French, German, and United Kingdom (UK) societal perspectives. Methods: This analysis was based on a retrospective analysis of RCC pts with bone metastases who were enrolled in a 9-mo trial of ZOL or placebo (PBO) plus concomitant antineoplastic therapy. A model was developed to simulate costs and quality-adjusted life-years (QALYs) experienced by study pts. The model included data and assumptions regarding SRE incidence, mortality, drug and administration costs, SRE costs, reduced quality of life (QOL) because of SREs and bone pain, and therapy duration. SRE costs were estimated using diagnosis-related group tariff information and published literature. Consistent with similar economic analyses, it was assumed that QOL decreased 20% to 80% (depending on SRE type) for 1 mo after each SRE experienced. Sensitivity analyses were performed to test the effects of alternate assumptions, with < 30,000/QALY considered cost-effective. Results: Compared with PBO-treated pts (n = 19), ZOL-treated pts (n = 27) experienced 1.07 fewer SREs/pt and gained discounted QALYs of approximately 0.1563 in France and Germany and 0.1575 in the UK. Discounted SRE-related costs were substantially lower among pts treated with ZOL vs PBO (-4,196 in France, -3,880 in Germany, and -3,355 in the UK). After including drug therapy costs, ZOL saved 1,358, 1,223, and 719 per pt in France, Germany, and the UK, respectively. In multivariate sensitivity analyses, ZOL saved costs in 67% to 77% of cases, depending on the country. ZOL resulted in a cost per QALY gained < 30,000 in approximately 93% of cases. Conclusions: Treatment with ZOL reduces SREs, improves QOL, and lowers health-related costs compared with PBO in French, German, and UK pts with bone metastases from RCC. Use of ZOL in these populations therefore provides health-related cost savings and is a cost-effective use of healthcare resources. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document